Etanercept - can it be used in the treatment of endotoxemia?;Etanersept - endotoksemi tedavisinde kullanılabilir mi?

Kafkas Universitesi Veteriner Fakultesi Dergisi

Volumn 19, Issue 1, 2013, Pages 133-139

  Er, Ayse ^a   Dik, Burak ^a   Cetin, Gul ^b   Altan, Feray ^c   Uney, Kamil ^a   Elmas, Muammer ^a   Yazar, Enver ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b MEHMET AKIF ERSOY UNIVERSITY   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

Author keywords

Endotoksemi; Etanersept; Pihtila ma; Prostaglandin; Sitokinler

Indexed keywords

EID: 84870919055     PISSN: 13006045     EISSN: None     Source Type: Journal    
DOI: 10.9775/kvfd.2012.7357     Document Type: Article

References (52)

1. Van Amersfoort ES, Van Berkel TJ, Kuiper J: Receptors, mediators, andmechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev, 16, 379-414, 2003.
2. Lopez-Bojorquez LN, Dehesa AZ, Reyes-Teran G: Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res, 35, 465-479, 2004.
3. Opal SM: The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol, 297, 365-377, 2007.
4. Buttenschoen K, Radermacher P, Bracht H: Endotoxin elimination in sepsis: Physiology and therapeutic application. Langenbecks Arch Surg, 395, 597-605, 2010.
5. Davies B, Cohen J: Endotoxin removal devices for the treatment of sepsisand septic shock. Lancet Infect Dis, 11, 65-71, 2011.
6. Er A, Yazar E: Effects of macrolide antibiotics on blood inflammatory mediators and organ damage markers in lipopolysaccharide-induced pulmonary damage rats. Eurasian J Vet Sci, 26, 7-13, 2010.
7. Coskun A, Sen I: Acute phase response and clinical changes in calves with lipopolysaccharide induced endotoxemia. Eurasian J Vet Sci, 28, 21-26, 2012.
8. Reimold AM: New indications for treatment of chronic inflammation by TNF-alpha blockade. Am J Med Sci, 325, 75-92, 2003.
9. Karabacak A, Yazar E: Current approaches in the treatment of septic shock. Eurasian J Vet Sci, 22, 95-103, 2006.
10. Ganidagli S, Gedik R, Koruk S, Mizrak A: Yoǧun baki{dotless}mda koagülasyon. TAD, 6, 36-44, 2008.
11. Kaya S: Narkotik olmayan aǧri{dotless} kesiciler. In, Kaya S, Pirinçci İ, Bilgili A(Eds): Veteriner Hekimliǧinde Farmakoloji. 2. Baski{dotless}, s. 373-400, Medisan Yayi{dotless}nlari{dotless}, Ankara, 2002.
12. Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett, 438, 159-160, 1998.
13. 2α in endotoxemia: A different approach. Eurasian J Vet Sci, 26, 15-19, 2010.
14. Yazar E, Er A, Uney K, Bulbul A, Avci GE, Elmas M, Tras B: Effects of drugs used in endotoxic shock on oxidative stress and organ damage markers. Free Radic Res, 44, 397-402, 2010.
15. Turgut K: Karaciǧer hastali{dotless}klari{dotless} ve testleri-Endokrin, metabolik ve lipidbozukluklari{dotless} ve testleri. In, Veteriner Klinik Laboratuar Teşhis. 2. Baski{dotless}. s. 202-486, Bahçi{dotless}vanlar Basi{dotless}m Sanayi, Konya, 2000.
16. Yurt AO: Effect of meloxicam on serum vitamin and cytokine levels during endotoxemia. Eurasian J Vet Sci, 28, 47-53, 2012.
17. Taban M, Dupps WJ, Mandell B, Perez VL: Etanercept (enbrel)-associated inflammatory eye disease: Case report and review of the literature. Ocul Immunol Inflamm, 14, 145-50, 2006.
18. Guo Z, Wang S, Jiao Q, Xu M, Xu Z: Soluble TNFR II/IgG1 Fc fusion proteintreatment in the LPS-mediated septic shock of rats. Biomed Pharmacother, 63, 537-542, 2009.
19. Yazar E, Bulbul A, Avci GE, Er A, Uney K, Elmas M, Tras B: Effects of enrofloxacin, flunixin meglumine and dexamethasone on disseminated intravascular coagulation, cytokine levels and adenosine deaminase activityin endotoxaemia in rats. Acta Vet Hung, 58, 357-367, 2010.
20. Tukov FF, Luyendyk JP, Ganey PE, Roth RA: The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Toxicol Sci, 100, 267-280, 2007.
21. Ness RD: Rodents. In, Carpenter JW (Ed): Exotic Animal Formulary. Thirdedition, p. 377-410, Elsevier Saunders, Pennsylvania, USA, 2004.
22. Tasgin E, Lok S, Demir N: Combined usage of testosterone and nandrolone may cause heart damage. African J Biotechnol, 10, 3766-3768, 2011.
23. Buyukleblebici O, Karagul H: Streptozotosin ile deneysel olarak diyabetoluşturulan ratlarda kromun biyokimyasal etkisi. Kafkas Univ Vet Fak Derg, 18, 21-26, 2012.
24. Er A, Uney K, Altan F, Cetin G, Yazar E, Elmas M: Effects of different dosesof dexamethasone plus flunixin meglumine on survival rate in lethal endotoxemia. Acta Vet Beograd, 59, 47-51, 2009.
25. Irmak K, Civelek T: Septik şok şüpheli neonatal buzaǧi{dotless}larda serum nitrikoksit (NO) konsantrasyonlari{dotless}. Kafkas Univ Vet Fak Derg, 10, 65-67, 2004.
26. Citil M, Karapehlivan M, Gunes V, Atakisi E, Uzlu E: Septisemi şüpheli buzaǧi{dotless}larda serum sialik asit ve bazi{dotless} biyokimyasal parametre düzeyleri. Kafkas Univ Vet Fak Derg, 10, 19-22, 2004.
27. Demirel MA, Kuplulu Ş: Investigation on the antiendotoxic effect of the combination of polymyxine and ampicillin in dogs with endotoxic pyometra. Kafkas Univ Vet Fak Derg, 16, 313-318, 2010.
28. Yazar E, Konyalioglu S, Col R, Birdane YO, Bas Al, Elmas M: Effects of vitamin E and prednisolone on some oxidative stress markers in endotoxemicrabbits. Revue Med Vet, 155, 538-542, 2004.
29. Keskin E, Oztekin E, Col R, Sivrikaya A, Uney K, Yazar E: Effect of pentoxifylline on antioxidant status of healthy and endotoxemic New Zealand white rabbits. Acta Vet Brno, 74, 17-21, 2005.
30. Konyalioglu S, Er A, Uney K, Elmas M, Yazar E: Effect of flunixin megluminon the antioxidant status in endotoxemia. Acta Vet Beograd, 57, 241-246, 2007.
31. Er A, Altan F, Cetin G, Uney K, Tras B, Elmas M, Yazar E: Effects of enrofloxacin, flunixin and dexamethasone on indicators of oxidative and organ damage in lipopolysaccharide induced endotoxemia. J Anim Vet Adv,9, 1495-1500, 2010.
32. Yazar E, Er A, Uney K, Altunok V, Elmas M: Effect of flunixin meglumineon cytokine levels in experimental endotoxemia in mice. J Vet Med A PhysiolPathol Clin Med, 54, 352-325, 2007.
33. Uney K, Er A, Avci GE, Bulbul A, Elmas M, Yazar E: Effect of tilmicosin on serum cytokine levels in the endotoxemia. J Anim Vet Adv, 8, 1021-1024,2009.
34. Er A, Yazar E, Uney K, Elmas M, Altan F, Cetin G: Effects of tylosin on serum cytokine levels in healthy and lipopolysaccharide-treated mice, ActaVet Hung, 58, 75-81, 2010.
35. Vuolteenaho K, Moilanen T, Hamalainen M, Moilanen E: Effects of TNFalpha-antagonists on nitric oxide production in human cartilage. Osteoarthritis Cartilage, 10 (4): 327-32, 2002.
36. Shen C, Assche GV, Colpaert S, Maerten P, Geboes K, Rutgeerts P, Ceuppens JL, Adalimumab induces apoptosis of human monocytes: A comparative study with infliximab and etanercept. Aliment Pharm Ther, 21, 251-258, 2005.
37. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, AbrahamE, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosisfactor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med, 334, 1697-1702, 1996.
38. Redman CM, Xia H: A review of the expression, assembly, secretion and intracellular degradation of fibrinogen. Fibrinolysis and Proteolysis, 14 (2-3): 198-205, 2000.
39. Mateus L, Lopes da Costa L, Diniz P, Ziecik AJ: Relationship betweenendotoxin and prostaglandin (PGE2 and PGFM) concentrations and ovarianfunction in dairy cows with puerperal endometritis. Anim Reprod Sci, 76, 143-154, 2003.
40. Hagman R, Kindahl H, Fransson BA, Bergstrom A, Holst BS, Lagerstedt AS: Differentiation between pyometra and cystic endometrial hyperplasia/mucometra in bitches by prostaglandin F2alpha metabolite analysis. Theriogenology, 15, 198-206, 2006.
41. Bawolak MT, Touzin K, Moreau ME, Desormeaux A, Adam A, MarceauF: Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: Effects of LPS, anti-inflammatory and anti-hypertensive drugs. Regul Pept, 146, 157-168, 2008.
42. Paiotti AP, Ribeiro DA, Silva RM, Marchi P, Oshima CT, Neto RA, Miszputen SJ, Franco M: Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats. J Mol Histol, 2012. DOI 10.1007/s10735-012-9400-8
43. Yazar E, Col R, Konyalioglu S, Birdane YO, Elmas M, Bas Al: Effects of vitamin E and prednisolone on biochemical and haematological parametersin endotoxaemic New Zeland white rabbits. Bull Vet Ins Pulawy, 48, 105-108, 2004.
44. Makwana N, Baines PB: Myocardial dysfunction in meningococcal septic shock. Curr Opin Crit Care, 11, 418-423, 2005.
45. Elmas M, Yazar E, Uney K, Er Karabacak A: Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacinafter intravenous administration in rabbits. J Vet Med A Physiol Pathol Clin Med, 53, 410-414, 2006.
46. Elmas M, Yazar E, Uney K, Er Karabacak A, Tras B: Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits. Vet J, 177, 418-424, 2008.
47. Choi DE, Jeong JY, Lim BJ, Na KR, Shin YT, Lee KW: Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury. Transplant Proc, 41, 3590-3696, 2009.
48. Yazar E, Col R, Uney K, Atalay B, Elmas M, Tras B: Effects of pentoxifylline on biochemical parameters in endotoxemic New Zeland white rabbits. Bull Vet Ins Pulawy, 48, 105-108, 2004.
49. Elmas M, Yazar E, Uney K, Karabacak A: Pharmacokinetics of flunixinafter intravenous administration in healthy and endotoxaemic rabbits. Vet Res Commun, 30, 73-81, 2006.
50. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C: Infection and inflammation-induced proatherogenic changes of lipoproteins. J InfectDis, 181, 462-472, 2000.
51. Mathieu S, Dubost JJ, Tournadre A, Malochet-Guinamand S, RistoriJM: Soubrier M. Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis. Joint Bone Spine, 77, 50-52, 2010.
52. Gisondi, P, Cazzaniga S, Chimenti, S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi L and Psocare Study Group: Metabolic abnormalities associated with initiation of systemic treatment for psoriasis:evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol, 2012 Feb 7. doi: 10.1111/j.1468-3083.2012.04450.x.